Zafgen Clinical Trials

Biopharma Industry Snapshot 2012 - MassBio
Biopharma Industry Snapshot 2012 Compiled with support from . MA BioPharma Employment Growth 37,490 53,253 Zafgen 33.0 Series C Verastem 32.0 Series B by clinical trials stage ... Doc Retrieval

FirstWord Pharma Daily News Round-Up Video For October 16 ...
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include AstraZeneca, Onglyza, Farxiga, FDA, Zafgen, beloranib, Cempra, solithromycin, PTC ... View Video

Franklin Biotechnology Discovery Fund
Franklin Biotechnology Discovery Fund Fund Manager Report has yet to move into Phase III trials. The company also develops other product candidates, which are in pre-clinical development stages. Edge including Zafgen, off-index ... View Doc

Corporate Summary - Galectin Therapeutics
Corporate Summary September 29, 2012 NASDAQ: GALT . clinical medicine, management and leadership, and business development. • Regis Tech., Decode, Zafgen, Boston College, Tokai Pharma, MIT, University of Dortmund, Harvard University ... Document Viewer

Galapagos Acquires Argenta Discovery 02.02 - MVM Life Science
Galapagos acquires Argenta Discovery’s service operations Antisoma, AstraZeneca, BioTie, Genentech, Novartis and Zafgen, Argenta adds strong Pulmagen intends to progress its programs through Phase IIa proof-of-concept clinical trials and identify strategic partners for later stage ... Access This Document

2015 R Apital Markets’ Healthcare Onference - Stock Quotes
Zafgen, Inc. (NASDAQ: ZFGN).. 19 dall Stanicky, CFA (Analyst) (212) 618-3266; randall.stanicky@rbc.com XTANDI [s clinical trials in earlier disease settings; and 3) emerging treatment candidates. Key takeaways: ... Read More

Franklin Biotechnology Discovery Fund
Zafgen is a biopharmaceutical company focused on the development of therapeutics for patients suffering from obesity and obesityrelated - disorders, including complex metabolic disorders. clinical trials for hormone therapy pharmaceutical products that are ... Retrieve Document

KOREA PHARM - Kpharma.org
KOREA PHARM 2015 The 5 th Korea Int’l Pharmaceutical Exhibition PREVIEW www. Phase 3 clinical trials for BKC003 (Kanarb + Statin), Phase IIb for severe obesity is ongoing by Zafgen, our licensed partner in the US. 2. ... Content Retrieval

BBC, The BioShares Biotechnology Clinical Trials Fund
Description of Fund: The BioShares Biotechnology Clinical Trials Fund (BBC) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the Life Sci Biotechnology Clinical Trials. ZFGN - ZAFGEN INC; ... Read Article

Beloranib - Wikipedia, The Free Encyclopedia
Beloranib is an experimental injectable [1] drug candidate for the treatment of obesity. It was discovered by CKD Pharmaceuticals and is currently being developed by Zafgen. ... Read Article

(Overweight/Maintain) - Kdbdw.com
Daewoong Pharmaceutical plans to initiate clinical trials for Nabota (wrinkle reduction treatment) in the US this year, with completion expected in late 2015. Phase 2 Zafgen - 2H14: Phase 3 for Prader-Wili syndrome indication and phase 2 for severe obesity indication Daewoong ... Access Full Source

Semiannual Report - Tekla Cap
Products in a variety of clinical trials have been impressive. The ultimate goal is to combine this new approach with existing drugs to Xencor, Inc. and Zafgen, Inc. During the same six month period, the Fund exited its position in several companies including, ... Fetch Content

GSK/Sirtris Compounds Dogged By Assay Artifacts
GSK/Sirtris compounds dogged by assay artifacts In January, scientists at Pfizer Global Research Massachusetts–based Zafgen, says he’s not surprised that GSK went after ing SRT501—currently in phase 2 clinical trials to treat type 2 diabetes—bind SIRT1 ... Return Doc

Obesity-Related Hypertension: Pathogenesis, Cardiovascular ...
VIVUS Inc, Takeda Pharmacueticals and Zafgen Inc. Dr. Aronne has ownership interest in Cardiometabolic Support Network LLC and Myos Corporation. CLINICAL TRIALS: BEHAVIORAL AND MEDICATIONS Obesity. The Pathophysiology of Obesity-Related ... Get Doc

IBTA E-News - Kræftens Bekæmpelse
Clinical trial of durvalumab in glioblastoma is now recruiting patients in Australia and USA A multicentre phase II trial to test the safety and effectiveness of durvalumab (MEDI4736) in . newly diagnosed glioblastoma patients has started recruiting patients in Melbourne, Australia, ... Return Doc

NASH Drugs Market, 2015 - 2025 - Researchandmarkets.com
Zydus Cadila and OCA by Intercept Pharmaceuticals) are in phase 3 clinical studies. are expected to complete the clinical trials of their respective molecules in the coming years, ViroBay and Zafgen. ... Return Doc

Jamesjungkuelee.files.wordpress.com
Zafgen MELK (maternal embryonic leucine zipper kinase), OTSSP167 is a highly potent MELK In January 2011, clinical trials being conducted by Merck were halted for patients with stroke and mild heart conditions.[2] ... Get Content Here

Where Do We Stand? Unraveling The FDA Regulatory Pathway For ...
Unraveling the FDA Regulatory Pathway for Diabetes and Obesity Drug Approval . Presenter Disclosure Takeda Pharmaceuticals, Teva, Time Cap, Vero, Zafgen. Stock/Shareholder: Exsulin Corporation Other: Kinexum, principle. • Event driven pivotal trials ... Retrieve Full Source

Drug Discovery For A New Generation Of Covalent Drugs
Advanced clinical trials to treat indications such as cancer and hepatitis C, ZGN-433 (Beloranib) (Zafgen Pharma) Biochemical target: Methionine aminopeptidase 2 Electrophilic site: Spiro-epoxide (covalent interaction with catalytic histidine) ... Read Content

Review - Prader-Willi California Foundation
Review . Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome . Additional clinical complications frequently found in PWS include excessive daytime sleepiness, research for treatment of hyperphagia in PWS was Zafgen, ... Retrieve Here